Name PRICE MARKET CAPITALIZATION PRICE TO EARNINGS RATIO DIVIDEND YIELD SYMBOL EXCHANGE PRICE PERCENT DIFFERENCE YEAR TO DATE PRICE PERCENT DIFFERENCE 5 YEAR CHART 1 YEAR CHART

Immune Design is a clinical-stage immunotherapy company. Its focus is next-generation in vivo methods intended to enable the body's immune system to fight diseases. The company's therapies have a broad potential approach across multiple therapeutic areas. Nevertheless, the company's target is oncology, and it is developing tumor-specific cytotoxic T cells to fight cancer. The main discoveries are CMB305 and G100, immuno-oncology approaches that are believed to address the shortcomings of existing oncological therapies.

http://www.immunedesign.com


IMDZ $5.85 +0.01 (0.17%)
Sector Health Care
Industry Biotech & Pharma
Market Cap 280 Million
EPS -0.29 P/E Ratio 0.00
Previous Earnings Wed, Aug 1, 2018
Latest Earnings Tue, Nov 6, 2018
Dividend --
Ex-Date --
Dividend Pay Date --
Dividend History --

5.85 0.28 0.00 0.00 IMDZ NASDAQ 0.17 339.85 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=IMDZ&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=IMDZ&exchange=NASDAQ&chart=1

Symbol Surfing has been referenced on Barrons, CNN & Investor Place.

About | Blog | Advertising | Terms | info@symbolsurfing.com

Investing Quotes #Legendary


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Some links on this website are advertisements and/or affiliate links and Symbol Surfing receives compensation.

©2019 Symbol Surfing All Rights Reserved. Privacy Policy | ^Top